Genetics of Women’s Cancers: New Opportunities Through Genomic Medicine
WebcastFaculty
OVERVIEW
Genetics of Women’s Cancers: New Opportunities Through Genomic Medicine is organized by Baptist Health South Florida and would be held during May 01, 2016 - May 01, 2018.
Target Audience:
Obstetricians, Gynecologists, Gynecologic Oncologists, Gynecologic Surgeons, Primary Care Physicians, Physician Assistants and Nurse Practitioners.This CME Conference has been approved with a maximum of 1.00 AMA PRA Category 1 Credit.
The potential benefits of genomic medicine, or the use of an individual patient’s genomic information in clinical decision making, are increasingly being recognized. This course explores the evolution from “genetics to genomics,” providing the history of genetics and the genesis of cancer. Dr. Boyd discusses translational research in the genetics and molecular genetics of gynecologic and breast cancers and the molecular diagnostics of cancer using next-generation sequencing technology to inform the prevention and targeted treatment of cancer. This lecture was recorded at the fifth annual Omar Pasalodos, M.D., Memorial Lecture, which honors Dr. Pasalodos’ dedication to women’s healthcare, community outreach and education.
Learning Objectives:
• Recognize the critical role of genetics in cancer pathogenesis.
• Explain the evolution of cancer genomics, and the role of genomic medicine in cancer treatment, prognosis and diagnosis.
• Evaluate gynecologic and breast cancers based on their genomic architecture rather than site of origin.
Available Credit:
1.00 AMA PRA Category 1 Credit
1.00 Nurse Practitioners
1.00 General certificate of attendance
Additional details will be posted as soon as they are available.
Target Audience:
Obstetricians, Gynecologists, Gynecologic Oncologists, Gynecologic Surgeons, Primary Care Physicians, Physician Assistants and Nurse Practitioners.This CME Conference has been approved with a maximum of 1.00 AMA PRA Category 1 Credit.
The potential benefits of genomic medicine, or the use of an individual patient’s genomic information in clinical decision making, are increasingly being recognized. This course explores the evolution from “genetics to genomics,” providing the history of genetics and the genesis of cancer. Dr. Boyd discusses translational research in the genetics and molecular genetics of gynecologic and breast cancers and the molecular diagnostics of cancer using next-generation sequencing technology to inform the prevention and targeted treatment of cancer. This lecture was recorded at the fifth annual Omar Pasalodos, M.D., Memorial Lecture, which honors Dr. Pasalodos’ dedication to women’s healthcare, community outreach and education.
Learning Objectives:
• Recognize the critical role of genetics in cancer pathogenesis.
• Explain the evolution of cancer genomics, and the role of genomic medicine in cancer treatment, prognosis and diagnosis.
• Evaluate gynecologic and breast cancers based on their genomic architecture rather than site of origin.
Available Credit:
1.00 AMA PRA Category 1 Credit
1.00 Nurse Practitioners
1.00 General certificate of attendance
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links